Robert F. Kennedy Jr., the nominee for HHS under President-elect Trump, has criticized reliance on the weight-loss drug Ozempic, advocating for addressing root causes of obesity. Kennedy Jr. opposes government funding for Ozempic and aims to focus on improving food systems and exercise to combat obesity.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
